| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CNR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | NUP160 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | MXRA7 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.06 |
| mRNA | FTSJ3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | OR6B2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | WIPI2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | MTMR9 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | SYNM | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | NBPF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BNC2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
